It might not be possible at this time to eradicate cancer altogether. But we may be able to stop cancer cells in their tracks through a process called senescence.

In senescence, cells don't divide. And when cells don't divide, they don't grow. In such a scenario then, cancer cells wouldn't divide and therefore couldn't grow.

Think about this:

According to lab tests on mice, triggering senescence in certain cells hampers the growth of some tumors.

Researchers at the University of Texas M.D. Anderson Cancer Center in Houston are the ones behind the scenes on this project -- the study appears online in EMBO Reports, a publication of the European Molecular Biology Organization -- and all eyes are on the p53 gene.

The p53 gene lives within cells and works to nip cancer in the bud by springing to action in damaged cells that may be spinning themselves into a cancer frenzy.

Researchers say senescence ordered by the p53 gene is extremely important in suppressing tumor formation and is as important as apoptosis -- a type of programmed cell death. But in some cancers, senescence might not be enough to halt cancer, they found.

OK, so senescence is not a perfect approach to halting all cancers. But it seems to work for some -- so I say for now, let's take what we can get.

Maryland's air has cancer-causing toxins, and they are far higher than the federal government considers safe, according to Environment Maryland -- an environmental group lobbying to make Maryland the 11th state to follow stricter auto emissions standards.

The group, a spin-off of the Maryland Public Interest Group, has released a report revealing the risk of cancer from air toxins was at least 10 times higher than federal standards in each of the state's counties and Baltimore City.

While California is currently setting the bar for higher auto emissions standards, there is no data at this time to compare Maryland's levels with the rest of the country.

On Sunday, for the very first time, I read a magazine article about the hospital where I received treatment for breast cancer. I had never before seen mention of my hospital, my doctors, my city in anything other than local and regional newspapers and on area television stations. I figured news about Shands Hospital at The University of Florida was out there -- in more areas than my own -- because it's a well-known facility. People travel from all over to receive treatment here. So I know it's a good place. But to see in the October 2006 issue of Good Housekeeping an actual blurb about a new kind of lumpectomy -- pioneered right here in Gainesville, Florida -- is exciting.

I am the happy recipient of this new kind of lumpectomy -- which really is not new at all. It was developed 20 years ago by the surgeon who performed my own lumpectomy, and it allows women who undergo lumpectomy the chance to avoid return trips to the operating room.

The method is called frozen section analysis, and it was first used by Dr. Edward Copland III, first director of the UF Shands Cancer Center, who was tired of waiting for pathology reports and tired of operating on patients two and three times to ensure clear tumor margins.

It all happens like this -- a surgeon removes the breast cancer tumor, takes tissue samples, freezes them in an embedding compound, and sends them to a pathologist for immediate analysis. In a typical case, this frozen section process adds just 15 minutes to the operating time. If pathology reveals more tissue must be removed, the surgeon returns to the patient, still under anesthesia, and continues surgery. The patient does not need to return for more surgery.

Surgeons at most institutions rely on a method called permanent section analysis to determine whether or not cancerous cells remain along the margins of a tumor. The technique is labor-intensive, takes days to complete, and requires patients to return for additional surgery if margins are not clear. Surgeons using the frozen section method still consult permanent sections to confirm margins are clear -- but they are mostly certain of their findings during frozen section.

Studies show frozen section analysis to be safe and effective -- and it adds just $851 to the cost of surgery, a savings considering the cost of returning for surgery as a result of permanent analysis.

There are many advantages -- but the procedure is tricky and on occasion can fail to detect some cancerous margins, indicating frozen section should continue to be used in conjunction with permanent section. Opponents of the practice say false positives could result in unnecessary mastectomy. But Copeland says this has never happened at UF -- and he would never remove a woman's breasts until permanent section confirmed it was necessary.

Despite the promise of this method, only a handful of institutions make practice of this surgery-sparing technique. Shands at UF is the only hospital in North Florida where breast surgeons perform frozen section analysis on a regular basis.

The procedure -- which is not risky, is not harmful, and clearly saves patients from returning for surgery -- is the exact procedure I received almost two years ago. Dr. Copeland removed my tumor, froze tissue samples, sent them to pathology, and 15 minutes later knew my tumor had clear margins and had not spread to my lymph nodes. He visited my family in the hospital waiting room just after surgery and told them the good news -- clear margins, no spread, a 1.1 cm. tumor, stage I. And while other tumor criteria, such as ER/PR status and HER2 status, did not come my way immediately, I at least knew the basics when I woke from surgery. No waiting. No worrying. No complaints.

Since 1988, Wendy Chioji has been a reporter and anchorwoman for WESH 2 News in Orlando, Florida. She has covered news ranging from the pope's visit to Cuba in 1998 to the Olympic Winter Games in Salt Lake City in 2002. She continuously covered last year's hurricanes, and she has an Emmy award under her belt for a special news report on heroin use.

Wendy is a top notch athlete. She has run five marathons and competed in several triathlons and half-ironman races. She has ridden in parts of several stages of the Tour de France, and traveled across the country with Lance Armstrong in 2003 -- covering 550 miles -- with the Tour of Hope event to raise awareness for cancer research. Wendy has also made a tour with stage II breast cancer. Since 2001, she has been surviving this disease.

Most current media reports have us believing that incidences of cancer are at epidemic proportions. What isn't making headlines is the fact that for many cancers, incidences of the disease are on the decline. This is what the American Council on Science and Health states as a result of a new report released from the North American Association of Central Cancer Registries, the American Cancer Society, and the Centers for Disease Control and Prevention. If only reports like this were splashed all over our newspapers and television screens -- instead of grim reports of increasing diagnoses and deaths -- then maybe the outlook on cancer would be a bit more hopeful.

Rates of colorectal cancer, uterine cancer, stomach cancer, and cervical cancer have all been declining for two years. Drops in cases are mostly attributed to lower rates of smoking, better screening, and better treatments. For men, lung cancer death rates have also fallen.

So not all incidences of all cancers have dropped -- but some have. And this should at least keep us hoping, dreaming, wishing for a day when cancer is not even loosely associated with the word epidemic. And it should surely be cause for at least some media coverage.

It does not surprise me that the Cleveland Clinic Cancer Center is among the best in the nation -- with internationally recognized physicians -- because I have always known this hospital to be the one stop where all medical difficulties and mysteries might be best managed -- in Ohio anyway. Growing up just an hour away from this facility, I thought maybe this was just the best Ohio hospital and that people headed here when other area hospitals could not deliver the best care. But now I know that the Cleveland Clinic is a destination for people from many states and countries. U.S. News & World Reports names the Cleveland Clinic one of the nation's top three hospitals, the clinic's heart program is ranked number one, it boasts a highly successful Children's Hospital, and cancer patients travel from all over the world for leading-edge cancer care at the Cleveland Clinic Taussig Cancer Center. There is even a Cleveland Clinic location in Florida. This hospital -- that I once believed was nothing more than a local healing place -- has quite a reach. And quite a reputation.

When Denise Ashford was 14 weeks pregnant, a fetal ultrasound scan revealed signs of a tumor in her unborn child. Her child had cancer. The young mother, only 19 years old at the time, was counseled on having an abortion. The cancer her baby had was neuroblastoma, a cancer that forms in nerve tissue of the adrenal gland, neck, chest, or spinal cord. Ashford, and the father Peter Thomas, refused to consider aborting the baby -- they said they would hang on for a miracle.

Each week, tests were done to watch how the unborn baby's tumor was growing. Within weeks, the tumor had begun to shrink.

"The doctors told us that sometimes in very small children this type of tumor can shrink over time. But then over the next four weeks, we were given some even more unbelievable news -- the tumor had disappeared altogether," stated Ashford.

Kiah Thomas came into this world at 6 pounds 1 ounce, and celebrates her fifth birthday as a happy healthy child. At the time of her birth, doctors said it was very rare for cancer to be detected in a baby before birth and then for it to disappear. But it happens. Called spontaneous remission, regression or miracles, stories of cancer patients defying the greatest of odds or having cancer suddenly disappear have always been told, as anecdotal evidence of mysteries we do not fully understand or have yet to seriously study.

For more information about spontaneous remission, the Institute of Noetic Sciences has compiled the largest database of medically reported cases of spontaneous remission in the world by reviewing over 3,500 references, from more than 800 journals in 20 languages, as a step towards expanding our knowledge and understanding of a real phenomenon that occurs, and yet, no one can explain.